Show an ad over header. AMP

I am the FIRST!!!

Biden gets swift blowback for booster plan at home and abroad

Wednesday's announcement that all Americans will be eligible for COVID-19 boosters eight months after their second dose was met with skepticism at home and opposition abroad.

Driving the news: Many public health experts criticized the decision as premature or even unethical, and that eight months is too long — vulnerability can return as soon as five months after the second dose.


  • The WHO slammed the U.S. for planning third shots while so many around the world haven't had their first.

Starting Sept. 20, Americans who received the Pfizer or Moderna vaccine should expect to be offered a third dose.

  • On the J&J vaccine, Biden health officials say they're waiting for more data before making the recommendation for a booster shot.

The big picture: There's still a global shortage of vaccines, and the announcement will only increase the pressure on the U.S. to do more to vaccinate the rest of the world.

  • Physicians and medical ethicists say it's difficult to justify a third dose for relatively healthy people given the global need.

regular 4 post ff

infinite scroll 4 pff

Women's soccer will get major U.S. exposure this weekend

Women's soccer will get major U.S. exposure this weekend, with the NWSL kicking off its seven-week "Fall Series" on CBS and the FA Women's Super League (England) beginning its season on NBCSN.

Why it matters: It's an exciting time for the sport, which has grown from four million players worldwide in 2006 to roughly 30 million today, and is still riding the momentum of the 2019 Women's World Cup.

Keep reading...Show less

FDA authroizes emergency use of Regeneron antibody treatment given to Trump

The Food and Drug Administration announced Saturday evening it has granted emergency use authorization for Regeneron Pharmaceuticals' antibody cocktail given to President Trump to treat his COVID-19 infection last month.

Why it matters: Regeneron's two monoclonal antibodies, casirivimab and imdevimab, are for people who tested positive for the coronavirus and "who are at high risk for progressing to severe COVID-19," including people who are 65 and older, and/or people with certain chronic illnesses, per an FDA statement.

Keep reading...Show less

Your guide to Congress' certification of Biden's win

There's no doubt about the outcome — Congress will ratify Joe Biden's election win and he'll be sworn in on Jan. 20 — but that won't stop today's political theater that may drag late into the night.

  • Here's our guide to watching the certification debate, with input from legislative aides, historians, election experts and Axios' Ursula Perano.
Keep reading...Show less

4 board members of Texas power grid operator ERCOT resign

Four members of Texas' power grid operator resigned from their posts Tuesday after a winter storm led millions of homes to lose power across the state last week, according to a public filing.

Why it matters: Their resignations come days after Texas' public utility commission launched a probe to discover the "factors that combined with the devastating winter weather to disrupt the flow of power," throughout the state.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;